Search Results

There are 7902118 results for: content related to: Unusual oral mucosa damage during telaprevir treatment of chronic hepatitis C

  1. Telaprevir: A Novel NS3/4 Protease Inhibitor for the Treatment of Hepatitis C

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 31, Issue 10, October 2011, Pages: 951–974, Olga M. Klibanov, Shannon H. Williams, Lisa S. Smith, Jacqueline L. Olin and Stephen B. Vickery

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.31.10.951

  2. You have free access to this content
    The effect of CYP3A inhibitors and inducers on the pharmacokinetics of telaprevir in healthy volunteers

    British Journal of Clinical Pharmacology

    Volume 75, Issue 2, February 2013, Pages: 431–439, Varun Garg, Gurudatt Chandorkar, Yijun Yang, Nathalie Adda, Lindsay McNair, Katia Alves, Frances Smith and Rolf P. G. van Heeswijk

    Version of Record online : 10 JAN 2013, DOI: 10.1111/j.1365-2125.2012.04345.x

  3. You have free access to this content
    Effectiveness and safety of reduced-dose telaprevir-based triple therapy in chronic hepatitis C patients

    Hepatology Research

    Volume 44, Issue 10, October 2014, Pages: E163–E171, Hitomi Sezaki, Fumitaka Suzuki, Tetsuya Hosaka, Norio Akuta, Taito Fukushima, Tasuku Hara, Yusuke Kawamura, Masahiro Kobayashi, Yoshiyuki Suzuki, Satoshi Saitoh, Yasuji Arase, Kenji Ikeda and Hiromitsu Kumada

    Version of Record online : 8 JAN 2014, DOI: 10.1111/hepr.12268

  4. Validation of a sensitive LC/MS/MS method for the determination of telaprevir and its R-isomer in human plasma

    Biomedical Chromatography

    Volume 28, Issue 12, December 2014, Pages: 1714–1721, Xinhui Chen, Lane R. Bushman, Kevin J. McAllister, Peter L. Anderson and Jennifer J. Kiser

    Version of Record online : 24 APR 2014, DOI: 10.1002/bmc.3211

  5. Telaprevir drug monitoring during antiviral therapy of hepatitis C graft infection after liver transplantation

    Liver International

    Volume 35, Issue 1, January 2015, Pages: 176–183, Harald Farnik, Tim Zimmermann, Eva Herrmann, Wolf O. Bechstein, Bernd Kronenberger, Peter R. Galle, Sandra Labocha, Nerea Ferreiros, Gerd Geisslinger, Stefan Zeuzem, Christoph Sarrazin and Martin W. Welker

    Version of Record online : 9 APR 2014, DOI: 10.1111/liv.12532

  6. You have free access to this content
    Clinical relevance of detectable but not quantifiable hepatitis C virus RNA during boceprevir or telaprevir treatment

    Hepatology

    Volume 55, Issue 4, April 2012, Pages: 1048–1057, Patrick R. Harrington, Wen Zeng and Lisa K. Naeger

    Version of Record online : 1 MAR 2012, DOI: 10.1002/hep.24791

  7. Cocrystalline Solids of Telaprevir with Enhanced Oral Absorption

    Journal of Pharmaceutical Sciences

    Volume 104, Issue 10, October 2015, Pages: 3343–3350, Kathy Stavropoulos, Steven C. Johnston, Yuegang Zhang, Bhisetti Govinda Rao, Michael Hurrey, Patricia Hurter, Elizabeth M. Topp and Irina Kadiyala

    Version of Record online : 11 JUN 2015, DOI: 10.1002/jps.24534

  8. Pharmacokinetic interaction between etravirine or rilpivirine and telaprevir in healthy volunteers: A randomized, two-way crossover trial

    The Journal of Clinical Pharmacology

    Volume 54, Issue 5, May 2014, Pages: 563–573, Thomas N. Kakuda, Lorant Leopold, Steven Nijs, Ann Vandevoorde, Herta M. Crauwels, Kirk M. Bertelsen, Marita Stevens, James Witek, Yvon van Delft, Frank Tomaka and Richard M.W. Hoetelmans

    Version of Record online : 3 APR 2014, DOI: 10.1002/jcph.245

  9. You have free access to this content
    Characterization of telaprevir treatment outcomes and resistance in patients with prior treatment failure: Results from the REALIZE trial

    Hepatology

    Volume 56, Issue 6, December 2012, Pages: 2106–2115, Sandra De Meyer, Inge Dierynck, Anne Ghys, Maria Beumont, Bjorn Daems, Ben Van Baelen, James C. Sullivan, Douglas J. Bartels, Tara L. Kieffer, Stefan Zeuzem and Gaston Picchio

    Version of Record online : 4 DEC 2012, DOI: 10.1002/hep.25962

  10. You have free access to this content
    HCV Therapeutics: Approved Agents

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 1091A–1168A,

    Version of Record online : 15 OCT 2013, DOI: 10.1002/hep.26880

  11. You have free access to this content
    Rapid emergence of telaprevir resistant hepatitis C virus strain from wildtype clone in vivo

    Hepatology

    Volume 54, Issue 3, 2 September 2011, Pages: 781–788, Nobuhiko Hiraga, Michio Imamura, Hiromi Abe, C. Nelson Hayes, Tomohiko Kono, Mayu Onishi, Masataka Tsuge, Shoichi Takahashi, Hidenori Ochi, Eiji Iwao, Naohiro Kamiya, Ichimaro Yamada, Chise Tateno, Katsutoshi Yoshizato, Hirotaka Matsui, Akinori Kanai, Toshiya Inaba, Shinji Tanaka and Kazuaki Chayama

    Version of Record online : 2 AUG 2011, DOI: 10.1002/hep.24460

  12. A practical guide for the use of boceprevir and telaprevir for the treatment of hepatitis C

    Journal of Viral Hepatitis

    Volume 19, Issue s2, May 2012, Pages: 1–26, I. M. Jacobson, J.-M. Pawlotsky, N. H. Afdhal, G. M. Dusheiko, X. Forns, D. M. Jensen, F. Poordad and J. Schulz

    Version of Record online : 8 MAR 2012, DOI: 10.1111/j.1365-2893.2012.01590.x

  13. Analysis of genotype 2 and 3 hepatitis C virus variants in patients treated with telaprevir demonstrates a consistent resistance profile across genotypes

    Journal of Viral Hepatitis

    Volume 20, Issue 6, June 2013, Pages: 395–403, S. De Meyer, A. Ghys, G. R. Foster, M. Beumont, B. Van Baelen, T.-I. Lin, I. Dierynck, H. Ceulemans and G. Picchio

    Version of Record online : 10 JAN 2013, DOI: 10.1111/jvh.12046

  14. You have free access to this content
    Comparative effectiveness of the hepatitis C virus protease inhibitors boceprevir and telaprevir in a large U.S. cohort

    Alimentary Pharmacology & Therapeutics

    Volume 39, Issue 1, January 2014, Pages: 93–103, L. I. Backus, P. S. Belperio, T. A. Shahoumian, R. Cheung and L. A. Mole

    Version of Record online : 10 NOV 2013, DOI: 10.1111/apt.12546

  15. Comparative safety study on severe anemia by simeprevir versus telaprevir-based triple therapy for chronic hepatitis C

    Journal of Gastroenterology and Hepatology

    Volume 30, Issue 8, August 2015, Pages: 1309–1316, Eiichi Ogawa, Norihiro Furusyo, Eiji Kajiwara, Hideyuki Nomura, Akira Kawano, Kazuhiro Takahashi, Kazufumi Dohmen, Takeaki Satoh, Koichi Azuma, Makoto Nakamuta, Toshimasa Koyanagi, Kazuhiro Kotoh, Shinji Shimoda, Jun Hayashi and The Kyushu University Liver Disease Study (KULDS) Group

    Version of Record online : 23 JUL 2015, DOI: 10.1111/jgh.12945

  16. You have free access to this content
    Drug therapy: Telaprevir

    Hepatology

    Volume 54, Issue 4, October 2011, Pages: 1463–1469, Michael D. Leise, W. Ray Kim, Katherine M. Canterbury and John J. Poterucha

    Version of Record online : 27 SEP 2011, DOI: 10.1002/hep.24660

  17. Ribavirin dose reduction during telaprevir/ribavirin/peg-interferon therapy overcomes the effect of the ITPA gene polymorphism

    Journal of Viral Hepatitis

    Volume 22, Issue 2, February 2015, Pages: 166–174, S. Akamatsu, C. N. Hayes, M. Tsuge, E. Murakami, N. Hiraga, H. Abe, D. Miki, M. Imamura, H. Ochi, K. Chayama and Hiroshima Liver Study Group

    Version of Record online : 16 JUN 2014, DOI: 10.1111/jvh.12275

  18. Comparative effectiveness and safety study of triple therapy with simeprevir or telaprevir for non-cirrhotic patients with chronic hepatitis C virus genotype 1b infection

    Journal of Gastroenterology and Hepatology

    Volume 30, Issue 12, December 2015, Pages: 1759–1767, Eiichi Ogawa, Norihiro Furusyo, Eiji Kajiwara, Hideyuki Nomura, Akira Kawano, Kazuhiro Takahashi, Kazufumi Dohmen, Takeaki Satoh, Koichi Azuma, Makoto Nakamuta, Toshimasa Koyanagi, Kazuhiro Kotoh, Shinji Shimoda and Jun Hayashi

    Version of Record online : 24 NOV 2015, DOI: 10.1111/jgh.13016

  19. Serum granulysin levels as a predictor of serious telaprevir-induced dermatological reactions

    Hepatology Research

    Volume 45, Issue 8, August 2015, Pages: 837–845, Goki Suda, Yoshiya Yamamoto, Astushi Nagasaka, Ken Furuya, Mineo Kudo, Yoshimichi Chuganji, Yoko Tsukuda, Seiji Tsunematsu, Fumiyuki Sato, Katsumi Terasita, Masato Nakai, Hiromasa Horimoto, Takuya Sho, Mitsuteru Natsuizaka, Kouji Ogawa, Shunsuke Ohnishi, Makoto Chuma, Yasuyuki Fujita, Riichiro Abe, Miki Taniguchi, Mina Nakagawa, Yasuhiro Asahina, Naoya Sakamoto and for the NORTE Study Group

    Version of Record online : 15 OCT 2014, DOI: 10.1111/hepr.12421

  20. Telaprevir with peginterferon/ribavirin for retreatment of null responders with advanced fibrosis post-orthotopic liver transplant

    Clinical Transplantation

    Volume 28, Issue 6, June 2014, Pages: 722–727, Paul Y. Kwo, Marwan Ghabril, Marco A. Lacerda, Alfred Joseph Tector, Jonathan A. Fridell and Rodrigo Vianna

    Version of Record online : 14 MAY 2014, DOI: 10.1111/ctr.12372